Ambulatory Surgery Centres Market: Global Industry Analysis and Forecast (2021-2027): by Ownership, Specialty Type, Service, and Region

Ambulatory Surgery Centres Market is anticipated to reach US$ 21.87 Bn. by 2027 from US$ 8.9 Bn. in 2020 at a CAGR of 11.9 % during a forecast period. ASCs are modern healthcare facilities in which procedures are conducted in fully equipped operating rooms by highly qualified physicians and nurses. These facilities typically serve patients who do not need to be admitted to hospitals for treatment. The therapy can be conducted outside of the hospital, and the patient can be discharged immediately once the medical operation is completed. Ambulatory surgery facilities are a good option for persons who cannot afford to pay large medical expenditures. Ambulatory Surgery Centres Market To know about the Research Methodology:- Request Free Sample Report In the report, 2020 is considered a base year however 2020’s numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

Ambulatory Surgery Centres Market Dynamics:

The global ambulatory surgical centers market is being driven largely by rising Medicare expenditure on ambulatory surgery centers and a greater emphasis on cost control in healthcare. Increasing the types of treatments offered at a single ASC provides a broader variety of reimbursement opportunities. In the report, the revenue impact of the covid-19 pandemic on the sales revenue of market leaders, market followers, and disruptors was examined, and this is represented in our analysis. ASCs are largely focused on an increasing number of facilities and procedures done. An increase in the frequency of accidents has increased demand for procedures, propelling the overall market growth. The expansion of ambulatory surgical centres is expected to outstrip that of the hospital outpatient surgical sector. Furthermore, market consolidation and technical developments have enabled ASCs to serve increasingly complex situations such as complete hip replacement, plasma treatment, major spine surgery, and platelet transfusion. Various healthcare organizations, such as Health Maintenance Organizations (HMOs), healthcare systems, and major group practices, are creating several specialist facilities inside the grounds of their primary healthcare facility to gain a competitive worldwide market share. This allows the facility to expand more quickly and earn a bigger market share. As a result, the industry is extremely competitive, and market participants are finding it difficult to profit. The global ambulatory surgical centers market is seeing a decline in the number of free-standing ambulatory surgical centers, as more centers are being built within larger facilities that offer a wider range of ambulatory care services to achieve economies of scale and gain a competitive edge.

Ambulatory Surgery Centres Market Segmentation Analysis

By Specialty Type, The multispecialty segment is expected to increase at a CAGR of around 5% during the forecast period, and it had the largest market share in 2020. By 2027, the rising prevalence of chronic illnesses would propel the multispecialty segment forward. The market for ambulatory surgical centres in the multispecialty category will be driven by physicians' & patients' preference for less invasive procedures, as well as increased Medicare expenditure on ASCs for a variety of surgeries like hysterectomy and lumbar spine surgery, to mention a few. By Ownership, The rising occurrence of diseases such as ophthalmic problems, diabetes, and other minor ailments that require expert care would increase the demand for specific treatment processes and specialized care requirements, which is expected to benefit single-specialty ASCs. Single-specialty centres are capable of giving disease-specific therapies that effectively enhance the patient's health. Physician-owned ASCs' reduced surgical procedure costs relative to other ASCs, minimal overheads, favorable reimbursements, and other related factors are expected to drive revenue growth in the Physicians Only category. The need for the therapy of many chronic ailments and diseases is expected to drive the growth of the hospitals and physicians segment. Hospital-physician collaborations are expected to help to reduce the limited treatment patterns that are designed to handle a specific disease, hence encouraging segment growth. Furthermore, rising rates of fungal, viral, and bacterial infections have resulted in an upward shift in demand for improved disease treatment, propelling the total ambulatory surgery centres market growth. By Service, Due to an increase in demand for dental care among the newborn and geriatric populations, the dental segment is expected to grow at a high rate. The senior population in the United States is expected to quadruple by 2027, boosting the market growth. The growth of the ambulatory surgical centres market will be aided by the fact that the baby population has the highest prevalence of cavities and other dental issues. The segment is expected to rise due to increased usage of cell phones and continued exposure to laptops and PCs at work. Furthermore, the emergence of minimally invasive surgical techniques for treating ocular problems would promote the market expansion of ambulatory surgical centres. The rising frequency of eye illnesses such as night blindness, cataracts, and other conditions has increased demand for procedures, boosting the ophthalmology segment's growth.

Ambulatory Surgery Centres Market Regional Insight

North America dominated the worldwide market in 2020 with a share of more than 39% and is expected to retain its dominance throughout the forecast period. The region's well-developed healthcare facilities, as well as the presence of many large-scale biotechnologies and medical device businesses, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker, are boosting the market growth. The increase in per capita income in the United States has greatly aided the population's ability to contribute to the healthcare industry. Furthermore, technical progress accelerates the market growth. The United States is expected to dominate the North American ambulatory surgical centres market due to a rise in the prevalence of old age disorders, which would necessitate more treatment at a lower cost. Skin and eye disorders have increased the need for procedures in India's ambulatory surgical centres market as a result of increased exposure to polluted air. Because of the rising need for operations, India is expected to have a considerable market position in the APAC ambulatory surgical centres market. Furthermore, technological advancements are expected to help in the provision of higher-quality medical devices to hospitals, resulting in market growth.

Report Objectives:

• Landscape analysis of the Ambulatory Surgery Centres Market • competitive benchmarking • Past and current status of the industry with the forecasted market size and trends • Evaluation of potential key players that include market leaders, followers, and new entrants • Technology trends • Potential impact of micro-economic factors of the market • External and Internal factors affecting market have been analysed The report also helps in understanding the Ambulatory Surgery Centres Market dynamics, structure by analysing the market segments and project the Ambulatory Surgery Centres Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Ambulatory Surgery Centres Market make the report investor’s guide.

Ambulatory Surgery Centres Market Scope: Inquire before buying

Ambulatory Surgery Centres Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US $ 8.9 Bn.
Forecast Period 2021 to 2027 CAGR: 11.9  % Market Size in 2027: US $ 21.87 Bn.
Segments Covered: by Ownership • Physician Owned • Hospital Owned • Corporation Owned • Physician & Hospital • Physician & Corporation • Hospital & Corporation
by Specialty Type • Single Specialty • Multispecialty
by Service • Dental • Urology • Otolaryngology • Endoscopy • Obstetrics/Gynecology • Ophthalmology • Orthopedic • Cardiovascular • Neurology • Cosmetic Surgery • Podiatry

Ambulatory Surgery Centres Market by Region

• North America • Asia pacific • Europe • Middle East and Africa • South America

Ambulatory Surgery Centres Market Key Players

Stryker Corp • Medtronic PLC • Zimmer Biomet • Novartis International AG • 21st Century Medicine • Biolife Solutions • Teva Pharmaceutical • Veloxis Pharmaceuticals • GlaxoSmithKline Plc • AbbVie Inc • Pfizer Inc • Astellas Pharma Inc • Gilead Sciences Inc • Quark Pharmaceuticals Inc • Takeda Pharmaceutical Company Ltd • Sanofi • Boehringer Ingelheim

Frequently Asked Questions

1. What is the projected market size & growth rate of Ambulatory Surgery Centres Market? Ans- Ambulatory Surgery Centres Market was valued at USD 8.9 billion in 2020 and is projected to reach USD 21.87 billion by 2027, growing at a CAGR of 11.9 % during the forecast period. 2. What are the key driving factors for the growth of Ambulatory Surgery Centres Market? Ans- The global ambulatory surgical centers market is being driven largely by rising Medicare expenditure on ambulatory surgery centers and a greater emphasis on cost control in healthcare. 3. Which Region accounted for the largest Ambulatory Surgery Centres Market share? Ans- North America dominated the worldwide market in 2020 with a share of more than 39% and is expected to retain its dominance throughout the forecast period. 4. What makes North America a Lucrative Market for Ambulatory Surgery Centres Market? Ans- The region's well-developed healthcare facilities, as well as the presence of many large-scale biotechnologies and medical device businesses, are driving the market growth.c 5. What are the top players operating in Ambulatory Surgery Centres Market? Ans- Stryker Corp, Medtronic PLC, Zimmer Biomet, Novartis International AG, 21st Century Medicine, Biolife Solutions, and Teva Pharmaceutical.
1. Global Ambulatory Surgery Centres Market: Research Methodology 2. Global Ambulatory Surgery Centres Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Ambulatory Surgery Centres Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Ambulatory Surgery Centres Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Ambulatory Surgery Centres Market Segmentation 4.1 Global Ambulatory Surgery Centres Market, By Ownership (2020-2027) • Physician Owned • Hospital Owned • Corporation Owned • Physician & Hospital • Physician & Corporation • Hospital & Corporation 4.2 Global Ambulatory Surgery Centres Market, By Specialty Type (2020-2027) • Single specialty • Multispecialty 4.3. European Ambulatory Surgery Centres Market, By Service (2020-2027) • Dental • Urology • Otolaryngology • Endoscopy • Obstetrics/Gynecology • Ophthalmology • Orthopedic • Cardiovascular • Neurology • Cosmetic Surgery • Podiatry 5. North America Ambulatory Surgery Centres Market (2020-2027) 5.1 North American Ambulatory Surgery Centres Market, By Ownership (2020-2027) • Physician Owned • Hospital Owned • Corporation Owned • Physician & Hospital • Physician & Corporation • Hospital & Corporation 5.2 North America Ambulatory Surgery Centres Market, By Specialty Type (2020-2027) • Single specialty • Multispecialty 5.3. European Ambulatory Surgery Centres Market, By Service (2020-2027) • Dental • Urology • Otolaryngology • Endoscopy • Obstetrics/Gynecology • Ophthalmology • Orthopedic • Cardiovascular • Neurology • Cosmetic Surgery • Podiatry 5.3 North America Ambulatory Surgery Centres Market, by Country (2020-2027) • United States • Canada • Mexico 6. Asia Pacific Ambulatory Surgery Centres Market (2020-2027) 6.1. Asia Pacific Ambulatory Surgery Centres Market, By Ownership (2020-2027) 6.2. Asia Pacific Ambulatory Surgery Centres Market, By Specialty Type (2020-2027) 6.3. European Ambulatory Surgery Centres Market, By Service (2020-2027) 6.4. Asia Pacific Ambulatory Surgery Centres Market, by Country (2020-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Ambulatory Surgery Centres Market (2020-2027) 7.1. Middle East and Africa Ambulatory Surgery Centres Market, By Ownership (2020-2027) 7.2. Middle East and Africa Ambulatory Surgery Centres Market, By Specialty Type (2020-2027) 7.3. European Ambulatory Surgery Centres Market, By Service (2020-2027) 7.4. Middle East and Africa Ambulatory Surgery Centres Market, by Country (2020-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Ambulatory Surgery Centres Market (2020-2027) 8.1. Latin America Ambulatory Surgery Centres Market, By Ownership (2020-2027) 8.2. Latin America Ambulatory Surgery Centres Market, By Specialty Type (2020-2027) 8.3. European Ambulatory Surgery Centres Market, By Service (2020-2027) 8.4 Latin America Ambulatory Surgery Centres Market, by Country (2020-2027) • Brazil • Argentina • Rest Of Latin America 9. European Ambulatory Surgery Centres Market (2020-2027) 9.1. European Ambulatory Surgery Centres Market, By Ownership (2020-2027) 9.2. European Ambulatory Surgery Centres Market, By Specialty Type (2020-2027) 9.3. European Ambulatory Surgery Centres Market, By Service (2020-2027) 9.4 European Ambulatory Surgery Centres Market, by Country (2020-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Stryker Corp 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Stryker Corp 10.3. Medtronic PLC 10.4. Zimmer Biomet 10.5. Novartis International AG 10.6. 21st Century Medicine 10.7. Biolife Solutions 10.8. Teva Pharmaceutical 10.9. Veloxis Pharmaceuticals 10.10. GlaxoSmithKline Plc 10.11. AbbVie Inc 10.12. Pfizer Inc 10.13. Astellas Pharma Inc 10.14. Gilead Sciences Inc 10.15. Quark Pharmaceuticals Inc 10.16. Takeda Pharmaceutical Company Ltd 10.17. Sanofi 10.18. Boehringer Ingelheim

About This Report

Report ID 8649
Category Healthcare
Published Date Aug2019
Updated Date Jan 2022
Contact Us